| BIOMARIN PHAR. DL-,001 | 71,420 / -1,58% |
| 日期/时间 | 21.01. / 21:59 |
| 涨跌。 / 涨跌。(%) | -1,150 / -1,58% |
| Bid | - |
| Ask | - |
| 打开 | 72,780 |
| 以往收市 | 72,570 |
| 高 | 72,910 |
| 低 | 71,420 |
| 成交量 [EUR] | 0,000 |
| 成交量 [Units] | 0 |
| Price fixings | 3 |
| ISIN | US09061G1013 |
| 符号 | BM8 |
| 交易所 | Stuttgart |
| 类型 | 股票 |
所有交易
| 交易所 | 最后的 | 成交量 | |
|---|---|---|---|
| NASDAQ | 86,8800 |  |
1.146.094 |
| IEX | 86,84 | |
54.627 |
| Cboe US | 86,75 | |
49.311 |
| London Inter.. | 87,08 |  |
818 |
| TradeGate | 71,720 | |
674 |
| Vienna Globa.. | 72,26 | |
142 |
| Frankfurt | 73,0900 |  |
45 |
| Xetra | 72,22 | |
0 |
| Berlin | 72,77 | |
0 |
| München | 72,56 | |
0 |
| Düsseldorf | 71,32 | |
0 |
| Stuttgart | 71,420 | |
0 |
| Lang & Schwa.. | 70,82 | |
|
| gettex | 71,330 | |
|
| Mexico | 1.599,31 | |
4.200 |
新闻
- BioMarin sinks 32% as FDA delays its hemophilia treatment
19.08.2020 / 16:23 - TeleTrader - Nasdaq turns red as pharma stocks fall
28.04.2020 / 16:48 - TeleTrader - BioMarin Enrolls First Participant in Phase 3 Trial of Vosoritide for Treatment of Children with Achondroplasia
12.12.2016 / 14:29 - GlobeNewswire - NICE Recommends BioMarin's Vimizim® (elosulfase alfa) for the Treatment of Morquio A Syndrome in England
23.11.2015 / 16:59 - GlobeNewswire